Royce & Associates’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-38,412
| Closed | -$1.13M | – | 1304 |
|
|
2017
Q3 | $1.13M | Sell |
38,412
-388,188
| -91% | -$10.9M | 0.01% | 930 |
|
|
2017
Q2 | $11.2M | Buy |
426,600
+386,600
| +967% | +$9.5M | 0.07% | 363 |
|
|
2017
Q1 | $936K | Hold |
40,000
| – | – | 0.01% | 991 |
|
|
2016
Q4 | $1.01M | Hold |
40,000
| – | – | 0.01% | 941 |
|
|
2016
Q3 | $1.12M | Hold |
40,000
| – | – | 0.01% | 912 |
|
|
2016
Q2 | $986K | Hold |
40,000
| – | – | 0.01% | 918 |
|
|
2016
Q1 | $884K | Hold |
40,000
| – | – | 0.01% | 944 |
|
|
2015
Q4 | $1.4M | Hold |
40,000
| – | – | 0.01% | 899 |
|
|
2015
Q3 | $1.14M | Hold |
40,000
| – | – | 0.01% | 953 |
|
|
2015
Q2 | $1.33M | Hold |
40,000
| – | – | 0.01% | 995 |
|
|
2015
Q1 | $1.13M | Hold |
40,000
| – | – | ﹤0.01% | 1011 |
|
|
2014
Q4 | $828K | Hold |
40,000
| – | – | ﹤0.01% | 1100 |
|
|
2014
Q3 | $977K | Sell |
40,000
-5,900
| -13% | -$156K | ﹤0.01% | 1129 |
|
|
2014
Q2 | $1.31M | Buy |
45,900
+3,400
| +8% | +$94.6K | ﹤0.01% | 1112 |
|
|
2014
Q1 | $1.19M | Hold |
42,500
| – | – | ﹤0.01% | 1126 |
|
|
2013
Q4 | $914K | Hold |
42,500
| – | – | ﹤0.01% | 1181 |
|
|
2013
Q3 | $564K | Sell |
42,500
-100,000
| -70% | -$1.35M | ﹤0.01% | 1231 |
|
|
2013
Q2 | $1.98M | Buy |
+142,500
| New | +$2.02M | 0.01% | 1053 |
|
Royce & Associates's PMC Position: Q4 2017 in Review
Royce & Associates sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 38,412 shares — an estimated $1.13M sold.
Royce & Associates first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $11.2M in Q2 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Royce & Associates reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Royce & Associates sold 38,412 PharMerica Corporation shares in Q4 2017, an estimated $1.13M.
- Royce & Associates first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Royce & Associates's PharMerica Corporation position peaked at $11.2M in Q2 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Royce & Associates's 13F filing for Q4 2017, filed 9 Feb 2018.